Amy Abernethy, the principal deputy commissioner and acting CIO of the Food and Drug Administration, discusses the agency’s plans to update its data strategy and technology to move with the speed of scientific advancement. Abernethy also explains the importance of leveraging innovative technology like AI and blockchain, migrating to the cloud, and public-private partnerships supporting the agency’s COVID-19 response efforts.
HealthCast
Season 1
Episode 23
29m listen
FDA’s Technology Modernization Vision
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
-
Amy Abernethy Principal Deputy Commissioner and Acting CIO FDA
Related Content
-
VA Testing Low-Cost Innovation for Health Care Solutions
The agency’s Innovation Unit uses low- to no-cost pilots to test new health care solutions before they reach veterans at home.
17m listen -
Why Storytelling Belongs in a Federal Leader’s Toolkit
Lucinda Wade and Mahua Mitra discuss the art of crafting compelling narratives and how to use the technique to inspire others.
19m listen -
Securing the Future of Open Source Software
Jack Cable and Remy DeCausemaker explore how CISA and CMS are tackling open source software (OSS) security in government.
4m listen -
How AI Will Continue to Advance Biometric Tech
At Identity Week, Arun Vemury discussed how error rates in facial recognition have dropped over the past decade thanks to machine learning.
12m listen